2017

2017

The Journal Club meetings are held at the Post Graduate Centre every Friday at 8am

Friday 6th January 2017 M&M (Morbidity and Mortality) meeting

Friday 13th January 2017 presented by Dr Aloysious Dominic Aravinthan ‘Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites’ . Dr Rajni Tiwari will be presenting the case.

Friday 20th January 2017 (to be held in the NDDC Seminar Room - West Block, D Floor, QMC) presented by Prof Krish Ragunath ‘Relationship between timing of endoscopy and mortality in patients with peptic ulcer bleeding: a nationwide cohort study’. Heuy Tan will be presenting the case.

Friday 27th January 2017 presented by Dr Gordon Moran ‘Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease’. Dr Jane Chalmers will be presenting the case.

Friday 3rd February 2017 M&M (Morbidity and Mortality) meeting

Friday 10th February 2017 (to be held in the NDDC Seminar Room - West Block, D Floor, QMC) presented by Dr Frank Philips ‘Crohn’s Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab’. Dr Pete Eddowes will be presenting the case.

Friday 17th February 2017 presented by Dr Waleed Fateen ‘Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients’. Dr Shiv Budilal will be presenting the case.

Friday 24th February 2017 presented by Prof Maura Corsetti ‘Current Trends in Functional Bowel Disease.’ During this presentation Maura will present the re-organization of the service for functional bowel patients including the GI Motility Lab.

Friday 3rd March 2017 M&M (Morbidity and Mortality) meeting

Friday 10th March 2017 presented by Emily Tucker ‘Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection’. Frank Philips will be presenting the case.

Friday 17th March 2017 presented by Madhavi Kasi ‘Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial’. Dr Tanya Monaghan will be presenting the case.

Friday 24th March 2017 presented by Dr Colin Crooks ‘Long term eff ects of once-only fl exible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial’. Dr Jane Chalmers will be presenting the case.